TECH Signal 326
NOAC blood thinners reportedly slow cognitive decline in Alzheimer’s patients with atrial fibrillation
↗
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners. The effect was modest each year but could add up over time.
This research suggests that NOAC blood thinners might provide a dual benefit for patients suffering from both Alzheimer's and atrial fibrillation. By potentially slowing cognitive decline, these medications could enhance the quality of life for patients. However, the observational nature of the study means further investigation is needed to confirm these findings.
Written by elseif from the cluster below · every claim links back to a sourceThe three things worth knowing
Patients taking NOACs showed a slower decline in cognitive function compared to those on warfarin or no anticoagulants.
The study analyzed data from 7,308 individuals diagnosed with both Alzheimer's disease and atrial fibrillation.
While NOACs have potential cognitive benefits, the study's observational design limits definitive conclusions.
THE READ
What the cluster adds up to.
The study indicates that non-vitamin K antagonist oral anticoagulants (NOACs) may offer a modest slowing of cognitive decline in Alzheimer's patients who also have atrial fibrillation. This suggests a potentially significant overlap in treatment benefits for this dual-diagnosis patient population.
NOACs, unlike traditional blood thinners such as warfarin, appear to not only reduce risks of stroke and blood clots but may also positively influence cognitive function over time. The observed effect, while modest at slightly more than 0.2 points on the Mini-Mental State Examination per year, could accumulate to meaningful differences in cognitive health.
However, the research is observational and lacks the rigor of randomized controlled trials, meaning causation cannot be firmly established. Factors influencing treatment choice and individual health changes may skew results, necessitating further studies to validate these findings.
Written by elseif from the cluster below · checked for specifics the sources never containedTHE CLUSTER